A prospective real-world study of efgartigimod in the treatment of chronic inflammatory demyelinating polyradiculoneuropathy - PubMed
4 hours ago
- #real-world study
- #CIDP
- #efgartigimod
- Prospective real-world study evaluates efgartigimod for CIDP treatment.
- 12 CIDP patients assessed using MRC, I-RODS, and INCAT scales.
- Significant improvement in muscle strength (MRC) and disability (I-RODS) scores observed.
- 91.7% of patients showed clinical improvement by the fifth week.
- No significant difference in efficacy between subcutaneous and intravenous administration.
- Low incidence of adverse events, with only one localized rash reported.
- Efgartigimod shows potential as a safe and effective CIDP treatment option.